Cargando…
Impact of Out-of-Pocket Costs on Prescription Fills Among New Initiators of Biologic Therapies for Rheumatoid Arthritis
BACKGROUND: Biologic disease-modifying antirheumatic drug (DMARD) therapies are a mainstay of treatment for rheumatoid arthritis (RA), yet high member out-of-pocket (OOP) costs for such therapies may limit patient access to these therapies. OBJECTIVE: To understand whether there is a relationship be...
Autores principales: | Hopson, Sari, Saverno, Kim, Liu, Larry Z., AL-Sabbagh, Ahmad, Orazem, John, Costantino, Mary E., Pasquale, Margaret K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397931/ https://www.ncbi.nlm.nih.gov/pubmed/27015251 http://dx.doi.org/10.18553/jmcp.2016.14261 |
Ejemplares similares
-
Out-of-Pocket Costs and Prescription Filling Behavior of Commercially Insured Individuals With Chronic Obstructive Pulmonary Disease
por: Patel, Bhavin, et al.
Publicado: (2022) -
Accuracy of Physician Estimates of Out-of-Pocket Costs for Medication Filling
por: Sloan, Caroline E., et al.
Publicado: (2021) -
Factors associated with physicians’ prescriptions for rheumatoid arthritis drugs not filled by patients
por: Kan, Hong J., et al.
Publicado: (2018) -
Trends in Out-of-Pocket Cost of Glucagon, 2010-2020
por: Zupa, Margaret, et al.
Publicado: (2022) -
Out of Pocket Costs and Variation in Panniculectomy Procedures
por: Oleru, Olachi, et al.
Publicado: (2023)